- ICH GCP
- Реестр клинических исследований ЕС
Страница клинических исследований Nct
Clinical Trial Results:
An open-label, multicenter extension study to evaluate the safety and tolerability of natalizumab in subjects with multiple sclerosis who have completed studies C-1801, C-1802, or C-1803.
Summary | |
EudraCT number | 2004-000047-18 |
Trial protocol | SE |
Global completion date | 06 Oct 2005 |
Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
Results information | |
Results version number | v1(current) |
This version publication date | 23 Mar 2016 |
First version publication date | 23 Mar 2016 |
Other versions | |
Summary report(s) | C1808 Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.